LÜBECK (dpa-AFX) - The medical and safety technology group Drägerwerk is once again raising its own targets at the end of the year. The SDax-listed company announced on Wednesday evening in Lübeck that both net sales and the operating profit margin for 2023 are likely to be better than recently forecast. The management now expects revenue to increase by more than 11% after adjusting for currency effects, compared to the previous upper end of the range of 11%. The operating margin is expected to be over four percent instead of between two and four percent as previously. The Group's share price rose by almost four percent following the news.

For 2022, Drägerwerk had reported net sales of around 3.05 billion euros and an operating loss of 88.6 million euros. This corresponds to a margin of -2.9 percent./ngu/men